![Evaluation of Outcomes in Converting from Intravenous Ondansetron to Oral Granisetron: An Observational Study | Semantic Scholar Evaluation of Outcomes in Converting from Intravenous Ondansetron to Oral Granisetron: An Observational Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2d0f012ad6d0e3ae0dc8e69c5872abcccf48e245/2-Table1-1.png)
Evaluation of Outcomes in Converting from Intravenous Ondansetron to Oral Granisetron: An Observational Study | Semantic Scholar
![Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics | Drug Metabolism & Disposition Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/highwire/dmd/47/3.cover-source.jpg)
Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics | Drug Metabolism & Disposition
View of Identification of Patients Eligible for IV-to-PO Conversion: A Cost-Minimization Study | Canadian Journal of Hospital Pharmacy
![Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics | Drug Metabolism & Disposition Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/47/3/257/F1.large.jpg)
Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics | Drug Metabolism & Disposition
![Association of High-dose Cyclophosphamide, Cisplatin, and Carmustine Pharmacokinetics with Survival, Toxicity, and Dosing Weight in Patients with Primary Breast Cancer | Clinical Cancer Research Association of High-dose Cyclophosphamide, Cisplatin, and Carmustine Pharmacokinetics with Survival, Toxicity, and Dosing Weight in Patients with Primary Breast Cancer | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/8/3/698/F1.large.jpg)
Association of High-dose Cyclophosphamide, Cisplatin, and Carmustine Pharmacokinetics with Survival, Toxicity, and Dosing Weight in Patients with Primary Breast Cancer | Clinical Cancer Research
![Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience Mendonca S, Gupta D, Ali S, Gupta P - Saudi J Kidney Dis Transpl Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience Mendonca S, Gupta D, Ali S, Gupta P - Saudi J Kidney Dis Transpl](https://www.sjkdt.org/articles/2017/28/5/images/SaudiJKidneyDisTranspl_2017_28_5_1069_215147_t5.jpg)